UGP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62470037423645E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.54871728961371E-15 |
Normal-vs-Stage2 |
3.60780000000505E-05 |
Normal-vs-Stage3 |
1.9354999825083E-09 |
Normal-vs-Stage4 |
6.24050000563869E-09 |
Stage1-vs-Stage2 |
7.089800E-01 |
Stage1-vs-Stage3 |
7.212400E-01 |
Stage1-vs-Stage4 |
5.744200E-01 |
Stage2-vs-Stage3 |
6.093800E-01 |
Stage2-vs-Stage4 |
5.168800E-01 |
Stage3-vs-Stage4 |
8.842200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.63002944475465E-12 |
Normal-vs-AfricanAmerican |
1.63713487211226E-12 |
Normal-vs-Asian |
1.27390000004279E-06 |
Caucasian-vs-AfricanAmerican |
2.548500E-02 |
Caucasian-vs-Asian |
3.141800E-01 |
AfricanAmerican-vs-Asian |
5.596000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62814206561279E-12 |
Normal-vs-Female |
2.46025422256935E-13 |
Male-vs-Female |
8.926400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.954500E-04 |
Normal-vs-Age(41-60Yrs) |
2.04924965885311E-12 |
Normal-vs-Age(61-80Yrs) |
1.64890323617328E-12 |
Normal-vs-Age(81-100Yrs) |
6.02719999465151E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.798600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.722600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.569200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.739600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.371800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.046400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.79540000000422E-06 |
Normal-vs-Grade 2 |
3.68299835074026E-11 |
Normal-vs-Grade 3 |
<1E-12 |
Normal-vs-Grade 4 |
2.19949999991087E-07 |
Grade 1-vs-Grade 2 |
4.508800E-01 |
Grade 1-vs-Grade 3 |
9.877000E-01 |
Grade 1-vs-Grade 4 |
5.099200E-01 |
Grade 2-vs-Grade 3 |
1.883230E-01 |
Grade 2-vs-Grade 4 |
9.838600E-01 |
Grade 3-vs-Grade 4 |
2.933800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.2815083156047E-13 |
Normal-vs-ccB subtype |
1.99070000483914E-08 |
ccA subtype-vs-ccB subtype |
3.136000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.91380244984884E-12 |
Normal-vs-N1 |
7.158000E-02 |
N0-vs-N1 |
6.602800E-01 |
|
|